These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15577316)

  • 1. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
    Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
    Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines.
    Thor Straten P; Kirkin AF; Seremet T; Zeuthen J
    Int J Cancer; 1997 Mar; 70(5):582-6. PubMed ID: 9052759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity.
    Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT
    J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
    Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
    Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
    Miyagi T; Tatsumi T; Takehara T; Kanto T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):32-40. PubMed ID: 12519221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
    Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
    Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced recognition of metastatic melanoma cells by autologous MART-1 specific CTL: relationship to TAP expression.
    Murray JL; Hudson JM; Ross MI; Zhang HZ; Ioannides CG
    J Immunother; 2000 Jan; 23(1):28-35. PubMed ID: 10687135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
    Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
    Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
    Maio M; Gulwani B; Morgano A; Ferrone S
    Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
    Corrias MV; Occhino M; Croce M; De Ambrosis A; Pistillo MP; Bocca P; Pistoia V; Ferrini S
    Tissue Antigens; 2001 Feb; 57(2):110-7. PubMed ID: 11260505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMME-based PDT restores expression and function of transporter associated with antigen processing 1 (TAP1) and surface presentation of MHC class I antigen in human glioma.
    Zhang SY; Li JL; Xu XK; Zheng MG; Wen CC; Li FC
    J Neurooncol; 2011 Nov; 105(2):199-210. PubMed ID: 21520005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
    BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regression.
    Dissemond J; Götte P; Mörs J; Lindeke A; Goos M; Ferrone S; Wagner SN
    Melanoma Res; 2003 Jun; 13(3):253-8. PubMed ID: 12777979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines.
    Pandha H; Rigg A; John J; Lemoine N
    Clin Exp Immunol; 2007 Apr; 148(1):127-35. PubMed ID: 17302733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients.
    Ugurel S; Uhlig D; Pföhler C; Tilgen W; Schadendorf D; Reinhold U
    Cancer Immunol Immunother; 2004 Jun; 53(6):551-9. PubMed ID: 14727087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression.
    Willers J; Urosevic M; Laine E; Geertsen R; Kündig T; Burg G; Dummer R
    J Invest Dermatol; 2001 Dec; 117(6):1498-504. PubMed ID: 11886514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.